Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.

10 Jul 2014

PTC Therapeutics initiates reimbursed expanded access program for Translarna

PTC Therapeutics, Inc. today announced the initiation of a reimbursed expanded access program (EAP). PTC's EAP program is intended to make Translarna (ataluren) available to patients before commercial availability in certain countries.

9 Jul 2014

Baptist Health, AFC partner to improve patient outcomes throughout Central Alabama

Today, Baptist Health and American Family Care announced that they have partnered to provide primary and urgent care services throughout Central Alabama.

9 Jul 2014

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Sheffield Hallam University has joined the fight against one of the UK's biggest cancer killers by launching its first Massive Open Online Course (MOOC) in Enhancing Prostate Cancer Care.

9 Jul 2014

Study on cancer care offers model for possible lower spending on treatment

The study, however, raised some questions because while it cut costs by a third and showed no decline in patient health, the spending on chemotherapy medications rose.

9 Jul 2014

Bowel cancer patients with high levels of vitamin D are more likely to survive the disease

Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.

9 Jul 2014

Researchers evaluate surgeons' cognition during robot-assisted surgery

What clues might brain metrics hold about the skill levels of surgeons who perform robot-assisted surgeries? Looking for better ways to assess the proficiency of surgeons performing these complex procedures, researchers at Roswell Park Cancer Institute (RPCI) and the University at Buffalo (UB) determined whether cognitive assessment can effectively measure the expertise of robotic surgeons with varying levels of experience.

9 Jul 2014

First Edition: June 9, 2014

Today's headlines include a status report on GOP discussions and debate over plans to replace the health law as well as coverage of emerging legislation to override the Supreme Court's Hobby Lobby decision.

9 Jul 2014

Auditor’s presence increases hand hygiene rates in healthcare workers

Hand hygiene rates were found to be three times higher when auditors were visible to healthcare workers than when there were no auditors present, according to a study in a major Canadian acute care hospital.

9 Jul 2014

Mercy Memorial Hospital System signs LOI to join Promedica

Mercy Memorial Hospital System signed a letter of intent to join ProMedica, a not-for-profit, multi-hospital system based in Toledo, Ohio.

9 Jul 2014

Hand hygiene rates 3 times higher when auditors visible to healthcare workers

9 Jul 2014

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study published this week in Nature Genetics.

8 Jul 2014

Genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma

Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature.

8 Jul 2014

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).

8 Jul 2014

Caregivers of cancer patients can manage end-of-life treatment, decisions with help from support team

Many caregivers of terminal cancer patients suffer depression and report regret and guilt from feeling they could have done more to eliminate side effects and relieve the pain.

8 Jul 2014

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Researchers at Roswell Park Cancer Institute (RPCI) have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast cancer.

8 Jul 2014

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).

7 Jul 2014

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity and diabetes.

7 Jul 2014

Transcription factor IRF4 plays key role in brown fat's thermogenic process

The body contains two types of fat cells, easily distinguished by color: White and brown. While white fat serves to store excess calories until they're needed by the body, brown adipocytes actually burn fat by turning it into heat.

4 Jul 2014

Beleodaq gets FDA approval for treatment of patients with peripheral T-cell lymphoma

The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action was taken under the agency's accelerated approval program.

3 Jul 2014

Oncology News and Research

Further Reading

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in moderate-to-severe AD

PTC Therapeutics initiates reimbursed expanded access program for Translarna

Baptist Health, AFC partner to improve patient outcomes throughout Central Alabama

Sheffield Hallam University launches online course in Enhancing Prostate Cancer Care

Study on cancer care offers model for possible lower spending on treatment

Bowel cancer patients with high levels of vitamin D are more likely to survive the disease

Researchers evaluate surgeons' cognition during robot-assisted surgery

First Edition: June 9, 2014

Auditor’s presence increases hand hygiene rates in healthcare workers

Mercy Memorial Hospital System signs LOI to join Promedica

Hand hygiene rates 3 times higher when auditors visible to healthcare workers

Genetic variants linked with greater risk for radiation-driven side effects in cancer patients

Genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma

Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study

Caregivers of cancer patients can manage end-of-life treatment, decisions with help from support team

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

AutoGenomics, Genomas sign agreement to develop DNA-guided diagnostic systems

Transcription factor IRF4 plays key role in brown fat's thermogenic process

Beleodaq gets FDA approval for treatment of patients with peripheral T-cell lymphoma

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News